A study of hepatobiliary involvement in adult patients with sickle cell disease


  • Ambika Prasad Mohanty Department of General Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India
  • Venkatesh Yellapu Department of General Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India
  • Kanduri Manoj Kumar Department of General Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India
  • Akshay Saxena Department of General Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India
  • Dandi Suryanarayana Deo Department of General Medicine, Kalinga Institute of Medical Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India




Sickle cell disease, hepatobiliary involvement, adult patients


Background: Sickle cell disease (SCD) encompasses a group of hemoglobinopathies characterized by a single amino acid substitution in the ß-globin chain. Hepatobiliary complications are frequent among sickle cell disease patients. Sickle cell disease has been extensively studied. However, data about hepatobiliary abnormalities among the adult age group are limited. Aim of our study aims to find the prevalence of hepatic-biliary involvement in Sickle cell disease in adult patients admitted to our hospital.

Methods: A prospective study was done for a period of two years from October 2017 to October 2019. Subjects of both sexes above the age of 18 years with SCD admitted to our hospital were enrolled. Thorough history taking, full clinical examination, hematological and biochemical parameters assessment, and abdominal ultrasonographic studies were performed to all patients.

Results: The results obtained showed that 59% of patients had hepatobiliary involvement. The most common symptom among these patients was bone pain, and the pallor was the most common sign. Biochemical tests revealed reduced hemoglobin concentration, elevated bilirubin, and compromised liver function. The most common ultrasound finding in this study was hepatomegaly, hepatosplenomegaly, cholelithiasis, and gall bladder sludge. The incidence of viral hepatitis was low compared to previous studies. Other hepatobiliary complications were cholelithiasis (14%), benign hyperbilirubinemia (14%), cholecystitis (8%) hepatic crisis (9%), hepatic sequestration (1%) , liver cirrhosis (1%), choledocholithiasis (1%) and cholangitis (1%).

Conclusions:Hepatobiliary complications, particularly gallbladder diseases, are frequent among SCD patients. The early detection of hepatobiliary complications by repeated ultrasound screening and liver function tests is significant as their frequency and intensity are related to the patient's age and the duration.



Mahera M M, Mansourb A H. Study of Chronic Hepatopathy in Patients with Sickle Cell Disease. Gastroenterology Research. 2009;2:338-343.

Issaa H, Al-Salem A H. Hepatobiliary Manifestations of Sickle Cell Anemia. Gastroenterology Research. 2010; 3(1):1-8.

Cage Johnson. Gall Bladder and Liver Disorders in Sickle Cell Disease: a Critical Review.2001 Available at (sickle.bwh.harvard.edu/liver.html).

Bokade CM, Chauhan U, Dhole C. Study of hepatobiliary involvement in children with sickle Cell Disease. Ann International medical and dental research.2017;3:9-15.

Choudhury VP.Hereditary Hemolytic Anemia. In: API Textbook of Medicine 11th ed, 2019; 915-29.

Bokade CM, Chauhan U, Dhole C. Study of Hepatobiliary Involvement in Children with Sickle Cell Disease. Ann. Int. Med. Den. Res. 2017; 3(3): P09-P15.

Johnson CS, Omata M, Tong MJ, Simmons JF, Jr., Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine.1985;64:349-356.

Mahebba A M Abdulla, Faire Juma Almoosa, Rana Juna Almoosa, A prospective study of the association between sickle cell disease and hepatobiliary effects in Bahran.2017:10:323-412

Dalia A. Saied , Mona S. El-Raziky 1, Mona K. El-Ghamrawy 1, Marwa A. Mahmoud Egyptian Pediatric Association Gazette 65 (2017) 54–59.

Sarkar P D, Agnihotram G, Skaria L K. Analysis of Liver Dysfunction among Sickle Cell Disease Population in Bastar Region of Chahatisgarh, J of Pharmaceutical and Biomedical Sciences.2012;1-7.

Almeida RP, Ferrera CD, Conceiçȁo J, Franca R, Lyra I, Silva LR. Hepatobiliary abnormalities in pediatric patients with sickle cell disease. Acta Gastroenterol Latinoam. 2009;38(2):112–117

Ebert EC, Nagar M, Hagspiel KD. Gastrointestinal and hepatic complications of sickle cell disease. ClinGastroenterolHepatol2010; 8:483-489.

Curtis SA, Danda N, Etzion Z, Cohen HW, Billett HH. Elevated steady-state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One. 2015;10(8):e01331.

Okpala I. The intriguing contribution of white blood cells to sickle cell disease – a red cell disorder. Blood Rev. 2004;18(1):65–73.

Mohanty J, Narayan J, Bhagat S, Panda BB et al. Sonological evaluation of abdominal organs in sickle cell crisis in Western Orissa. Indian J Radiol Imaging.2004;14:247-51.

Oparinde DP, Oghagbon EK, Okesina AB et al. Role of hepatic enzymes in the biochemical assessment of the severity of sickle cell anemia. Trop Gastroenterol. 2006; 27(3):118-21.

Papadaki MG et al. Abdominal ultrasonographic findings in patients with sickle cell anemia and thalassemia intermedia. Pediatr Radiol 2003Aug; 33(8): 515-21.

Eze CU, Offordile GC, Agwuna KK, Ocheni S, Nwadike IU, Chukwu BF. Sonographic evaluation of the spleen among sickle cell disease patients in a teaching hospital in Nigeria. Afr Health Sci. 2015;15:949–58.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.

Gumiero AP, Bellomo-Brandȁo, MA, Costa-Pinto EA. Gallstones in children with sickle cell disease followed at a Brazilian hematology center. Arq Gastroenterol. 2008;45(4):313–318

McCarville MB, Rogers ZR, Sarnaik S, Scott P, Araun B, Hilliard L, et al. Effects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemia. J Pediatr. 2012;160(2). 281–5.e1.

Traina F, Jorge SG, Yamanaka A, de Meirelles LR, Costa FF, Saad ST. Chronic liver abnormalities in sickle cell disease: a clinicopathological study in 70 living patients. Acta Haematol. 2007;118(3):129–135.

Koskinos J, Manesis EK, Zacharakis GH, Galiatsatos N, Sevastos N, Archimandritis AJ. Liver involvement in an acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors. Scand J Gastroenterol. 2007;42 (4):499–507.

Khan, MA, Kerner JA. Reversal of hepatic and renal failure from sickle cell intrahepatic cholestasis. Dig Dis Sci 2011.

Torres MC, Pereira LM, Ximenes RA, et al. Hepatitis C virus infection in a Brazilian population with sickle-cell anemia. Hepatitis C virus infection in sickle cell anemia. Braz J of Med Biol Res. 2003;36(3):323–329.

Hassan MF, March F, Posner G, et al. Chronic hepatitis C in patients with sickle cell disease. Am J Gastroenterol. 1996;91(6):1204–1206.

Ocak S, Kaya H, Cetin M, Gali E, Ozturk M. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res. 2006;37(7):895–898.

Green TW, Conley CL, Berthrong M. [The liver in sickle cell anemia]. BullJohnsHopkinsHosp 1953;92: 99-127.

Klion FM, Weiner MJ, Schaffner F. Cholestasis in Sickle Cell Anemia. AmJMed1964; 37: 829-832.






Original Research Articles